Cargando…

Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter

BACKGROUND: Coronavirus disease 2019 (COVID-19) has forced dramatic changes to the healthcare systems throughout the world. Time-sensitive management of cardiovascular emergencies such as ST-elevation myocardial infarction (STEMI) has yet to be evaluated in the context of these new policies, particu...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Kevin, Potter, Brian J., Matteau, Alexis, Gobeil, François, Mansour, Samer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501080/
https://www.ncbi.nlm.nih.gov/pubmed/32988743
http://dx.doi.org/10.1016/j.carrev.2020.09.024
_version_ 1783583982772813824
author Haddad, Kevin
Potter, Brian J.
Matteau, Alexis
Gobeil, François
Mansour, Samer
author_facet Haddad, Kevin
Potter, Brian J.
Matteau, Alexis
Gobeil, François
Mansour, Samer
author_sort Haddad, Kevin
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) has forced dramatic changes to the healthcare systems throughout the world. Time-sensitive management of cardiovascular emergencies such as ST-elevation myocardial infarction (STEMI) has yet to be evaluated in the context of these new policies, particularly in so-called “hot spot” cities. METHODS: We evaluated the early impact of the pandemic on STEMI performance in the Greater Montreal Area. A total of 167 patients from 3 different study periods were included. Patients presenting in the lockdown period from mid-March to mid-May 2020 (Group C, 53 patients) were compared to those from mid-March to mid-May 2019 (Group A, 60 patients) and the 2020 pre-COVID-19 period (Group B, 54 patients). RESULTS: The number of STEMI admissions was unaffected during the lockdown. However, significantly longer delays between symptom onset and first medical contact (FMC) were noted (Group C 189.0 IQR [70.0, 840.0] min vs. Group A 103.0 IQR [42.5, 263.0] min vs. Group B 91.0 IQR [38.0, 235.5 min], P = 0.007). In contrast, additional safety protocols do not appear to have significantly affected delays between FMC and first intracoronary device activation (Group C 102 IQR [73.0, 133.0] min vs. Group A 104 IQR [87.0, 146.0] min vs. Group B 99.5 IQR [80.0, 150.0] min, P = 0.37). Patients that presented during the outbreak were more likely to be unstable with a higher incidence of Killip classes II-IV compared to groups A and B (28.3% vs. 18.3% vs. 5.6% respectively, P = 0.008). Worse in-hospital outcomes were also noted with a significantly higher rate of major adverse cardiac events (Group A 5.0% vs. Group B 11.1% vs. Group C 22.6%, P = 0.007). CONCLUSION: During the lockdown period, many patients appear to have been reluctant to present to hospitals. This was associated with more unstable STEMI presentations and worse in-hospital course. Importantly, the health care system appears able to ensure timely acute cardiac care while ensuring that COVID-19 protocols are respected.
format Online
Article
Text
id pubmed-7501080
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-75010802020-09-21 Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter Haddad, Kevin Potter, Brian J. Matteau, Alexis Gobeil, François Mansour, Samer Cardiovasc Revasc Med Clinical BACKGROUND: Coronavirus disease 2019 (COVID-19) has forced dramatic changes to the healthcare systems throughout the world. Time-sensitive management of cardiovascular emergencies such as ST-elevation myocardial infarction (STEMI) has yet to be evaluated in the context of these new policies, particularly in so-called “hot spot” cities. METHODS: We evaluated the early impact of the pandemic on STEMI performance in the Greater Montreal Area. A total of 167 patients from 3 different study periods were included. Patients presenting in the lockdown period from mid-March to mid-May 2020 (Group C, 53 patients) were compared to those from mid-March to mid-May 2019 (Group A, 60 patients) and the 2020 pre-COVID-19 period (Group B, 54 patients). RESULTS: The number of STEMI admissions was unaffected during the lockdown. However, significantly longer delays between symptom onset and first medical contact (FMC) were noted (Group C 189.0 IQR [70.0, 840.0] min vs. Group A 103.0 IQR [42.5, 263.0] min vs. Group B 91.0 IQR [38.0, 235.5 min], P = 0.007). In contrast, additional safety protocols do not appear to have significantly affected delays between FMC and first intracoronary device activation (Group C 102 IQR [73.0, 133.0] min vs. Group A 104 IQR [87.0, 146.0] min vs. Group B 99.5 IQR [80.0, 150.0] min, P = 0.37). Patients that presented during the outbreak were more likely to be unstable with a higher incidence of Killip classes II-IV compared to groups A and B (28.3% vs. 18.3% vs. 5.6% respectively, P = 0.008). Worse in-hospital outcomes were also noted with a significantly higher rate of major adverse cardiac events (Group A 5.0% vs. Group B 11.1% vs. Group C 22.6%, P = 0.007). CONCLUSION: During the lockdown period, many patients appear to have been reluctant to present to hospitals. This was associated with more unstable STEMI presentations and worse in-hospital course. Importantly, the health care system appears able to ensure timely acute cardiac care while ensuring that COVID-19 protocols are respected. Elsevier Inc. 2021-09 2020-09-19 /pmc/articles/PMC7501080/ /pubmed/32988743 http://dx.doi.org/10.1016/j.carrev.2020.09.024 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical
Haddad, Kevin
Potter, Brian J.
Matteau, Alexis
Gobeil, François
Mansour, Samer
Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
title Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
title_full Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
title_fullStr Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
title_full_unstemmed Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
title_short Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
title_sort implications of covid-19 on time-sensitive stemi care: a report from a north american epicenter
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501080/
https://www.ncbi.nlm.nih.gov/pubmed/32988743
http://dx.doi.org/10.1016/j.carrev.2020.09.024
work_keys_str_mv AT haddadkevin implicationsofcovid19ontimesensitivestemicareareportfromanorthamericanepicenter
AT potterbrianj implicationsofcovid19ontimesensitivestemicareareportfromanorthamericanepicenter
AT matteaualexis implicationsofcovid19ontimesensitivestemicareareportfromanorthamericanepicenter
AT gobeilfrancois implicationsofcovid19ontimesensitivestemicareareportfromanorthamericanepicenter
AT mansoursamer implicationsofcovid19ontimesensitivestemicareareportfromanorthamericanepicenter